- Home
- SINT
as 11-07-2025 3:57pm EST
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
Upcoming Earnings Alert:
Get ready for potential market movements as SiNtx Technologies Inc. SINT prepares to release earnings report on 13 Nov 2025.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 11.6M | IPO Year: | 2014 |
| Target Price: | $25.00 | AVG Volume (30 days): | 411.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.71 - $8.60 | Next Earning Date: | 11-13-2025 |
| Revenue: | $1,861,000 | Revenue Growth: | -40.47% |
| Revenue Growth (this year): | -64.67% | Revenue Growth (next year): | 80.00% |
Stock Insider Trading Activity of SiNtx Technologies Inc. (SINT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Olson Eric K. | SINT | President and CEO | Oct 20 '25 | Buy | $3.40 | 5,800 | $19,720.00 | 30,775 | |
| MOYES JAY M | SINT | N/A | Aug 26 '25 | Buy | $3.59 | 3,000 | $10,756.20 | 3,000 | |
| Honigblum Gregg R. | SINT | Chief Investment Officer | Aug 26 '25 | Buy | $3.70 | 50,000 | $185,000.00 | 24,000 | |
| Olson Eric K. | SINT | President and CEO | Aug 22 '25 | Buy | $3.59 | 10,475 | $37,470.00 | 30,775 |
Latest SiNtx Technologies Inc. News
SINT Breaking Stock News: Dive into SINT Ticker-Specific Updates for Smart Investing
MT Newswires
19 days ago
Sintx Technologies Says Foot, Ankle Implant System Gets FDA Clearance; Shares Up Pre-Bell
GlobeNewswire
19 days ago
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
Zacks
23 days ago
What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?
GlobeNewswire
23 days ago
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
GlobeNewswire
25 days ago
SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics
GlobeNewswire
2 months ago
SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025
GlobeNewswire
2 months ago
SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds
GlobeNewswire
2 months ago
SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent
Compare SINT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SINT SiNtx Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.